WNT signaling and cancer stemness

M Katoh, M Katoh - Essays in biochemistry, 2022 - portlandpress.com
Cancer stemness, defined as the self-renewal and tumor-initiation potential of cancer stem
cells (CSCs), is a cancer biology property featuring activation of CSC signaling networks …

[HTML][HTML] Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells

H Li, Z Feng, ML He - Theranostics, 2020 - ncbi.nlm.nih.gov
Lipids, the basic components of the cell membrane, execute fundamental roles in almost all
the cell activities including cell-cell recognition, signalling transduction and energy supplies …

Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching

C Chen, S Zhao, X Zhao, L Cao, A Karnad… - Cell Death & …, 2022 - nature.com
Chemoresistance in pancreatic cancer cells may be caused by the expansion of inherently
resistant cancer cells or by the adaptive plasticity of initially sensitive cancer cells. We …

[HTML][HTML] Regulation of cancer stem cells in triple negative breast cancer

N Fultang, M Chakraborty… - Cancer Drug …, 2021 - ncbi.nlm.nih.gov
Abstract Triple Negative Breast Cancer (TNBC) is the most lethal subtype of breast cancer.
Despite the successes of emerging targeted therapies, relapse, recurrence, and therapy …

Nuclear factor erythroid 2-related factor 2 in regulating cancer metabolism

K Smolková, E Mikó, T Kovács… - Antioxidants & Redox …, 2020 - liebertpub.com
Significance: Nuclear factor erythroid 2 (NFE2)-related factor 2 (NFE2L2, or NRF2) is a
transcription factor predominantly affecting the expression of antioxidant genes. NRF2 plays …

Inflammation-driven breast tumor cell plasticity: Stemness/EMT, therapy resistance and dormancy

T Baram, L Rubinstein-Achiasaf, H Ben-Yaakov… - Frontiers in …, 2021 - frontiersin.org
Cellular heterogeneity poses an immense therapeutic challenge in cancer due to a constant
change in tumor cell characteristics, endowing cancer cells with the ability to dynamically …

FZD5 contributes to TNBC proliferation, DNA damage repair and stemness

Y Sun, Z Wang, L Na, D Dong, W Wang, C Zhao - Cell Death & Disease, 2020 - nature.com
Chemotherapy currently remains the standard treatment for triple-negative breast cancer
(TNBC). However, TNBC frequently develop chemoresistance, which is responsible for …

Potential role of MSC/cancer cell fusion and EMT for breast cancer stem cell formation

R Hass, J von der Ohe, H Ungefroren - Cancers, 2019 - mdpi.com
Solid tumors comprise of maturated cancer cells and self-renewing cancer stem-like cells
(CSCs), which are associated with various other nontumorigenic cell populations in the …

Clinically translatable approaches of inhibiting TGF-β to target cancer stem cells in TNBC

A Sulaiman, S McGarry, SC Chilumula, R Kandunuri… - Biomedicines, 2021 - mdpi.com
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that disproportionally
accounts for the majority of breast cancer-related deaths due to the lack of specific targets for …

Cancer stem cells in ovarian cancer—a source of tumor success and a challenging target for novel therapies

JR Wilczyński, M Wilczyński, E Paradowska - International Journal of …, 2022 - mdpi.com
Ovarian cancer is the most lethal neoplasm of the female genital organs. Despite
indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance …